[Breaking] "Five Domestic Companies Enter COVID-19 Vaccine Clinical Trials... Aim to Start Phase 3 in Second Half"
[Asia Economy Reporter Lim Juhyung] Domestic companies have officially begun clinical trials for the development of COVID-19 vaccines.
The Ministry of Health and Welfare reported the status of domestic vaccine development at the 'Special COVID-19 Response Quarantine Inspection Meeting' chaired by President Moon Jae-in on the 12th.
Hot Picks Today
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- "I'll Stop by Starbucks Tomorrow": People Power Chungbuk Committee and Geoje Mayoral Candidate Face Criticism for Alleged 5·18 Demeaning Remarks
- [New York Stock Exchange] All Major Indices Close Lower as U.S. Treasury Yields Surge
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
Currently, a total of five companies?SK Bioscience, UbioLogics, Cellid, Genexine, and GeneOne Life Science?have entered COVID-19 vaccine clinical trials, aiming to start Phase 3 clinical trials from the second half of this year.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.